| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |